Diamyd Medical AB (publ) (DMYD-B) — Cash Flow Reinvestment Rate

Latest as of November 2021: 2978.57x

Diamyd Medical AB (publ) (DMYD-B) has a Cash Flow Reinvestment Rate of 2978.57x as of November 2021, reinvesting Skr62.55 Million (capex Skr42.55 Million plus investments Skr-20.00 Million) from operating cash flow of Skr21.00K. Check DMYD-B operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

2978.57x

(Capex + Investments) / Operating CF

Total Reinvested

Skr62.55 Million

Capex + Investments

Operating Cash Flow

Skr21.00K

SEK

Capital Expenditures

Skr42.55 Million

SEK

Diamyd Medical AB (publ) Cash Flow Reinvestment Rate (2010–2020)

Historical reinvestment intensity for Diamyd Medical AB (publ) across 2 annual periods. Explore Diamyd Medical AB (publ) (DMYD-B) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Diamyd Medical AB (publ) (2010–2020)

Year-by-year capital reinvestment analysis for Diamyd Medical AB (publ). For live market cap and broader valuation context, see Diamyd Medical AB (publ) market capitalisation.

Year	Reinvestment Rate	Total Reinvested (SEK)	Operating CF	Capex	YoY Change
2020	0.52x	Skr8.78 Million	Skr16.88 Million	Skr1.98 Million	▲ +16674.5%
2010	0.00x	Skr700.00K	Skr225.77 Million	Skr700.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow